|
| |
| | | 68297 | | 07.11.2023 | | Roche Pharma (Schweiz) AG | | | | | | | 24.11.2030 | | | | | | | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Columvi 2.5 mg/2.5 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Glofitamabum 2.5mg / 2.5ml) | L01FX28 | | | 02 | Columvi 10 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Glofitamabum 10mg / 10ml) | L01FX28 | |
|
|
|
